Lotrafiban
Product Specifications
UNSPSC Description
Lotrafiban is an orally-active platelet GPIIb/IIIa blocker for research of coronary and cerebrovascular disease.
Target Antigen
Integrin
Type
Reference compound
Related Pathways
Cytoskeleton
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/lotrafiban.html
Solubility
10 mM in DMSO
Smiles
O=C1N(C)CC2=CC(C(N3CCC(C4CCNCC4)CC3)=O)=CC=C2N[C@H]1CC(O)=O
Molecular Weight
428.52
References & Citations
[1]Topol EJ, Easton D, Harrington RA, et al. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation. 2003;108(4):399-406.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-10314/Lotrafiban-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-10314/
Clinical Information
Phase 3
CAS Number
171049-14-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items